Isida Revenue and Competitors

Kyiv,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Isida's estimated annual revenue is currently $14.7M per year.(i)
  • Isida's estimated revenue per employee is $140,000

Employee Data

  • Isida has 105 Employees.(i)
  • Isida grew their employee count by 8% last year.

Isida's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$14.1M1015%N/AN/A
#2
$1.6M19-71%N/AN/A
#3
$212.8M10635%$65MN/A
#4
$6.8M548%N/AN/A
#5
$12.9M922%$23.1MN/A
#6
$1M12N/AN/AN/A
#7
$106.5M599-17%$2.3MN/A
#8
$35.6M2316%N/AN/A
#9
$38.3M2495%N/AN/A
#10
$45M299-4%$102.6MN/A
Add Company

What Is Isida?

ISIDA сlinic is a unique medical complex specializing in assisted reproduction, obstetrics and gynecology. The complexity of the clinic is in all-round care for women's health and the birth of healthy babies: its own laboratory, department of infertility treatment, gynecology, monitoring of pregnancy, childbirth and neonatology. Complexity of services allows making an accurate diagnose in short term and provide adequate effective treatment and further observation. All doctors in the ISIDA clinic are experienced professionals. The quality control system have been certified by independent international experts. ISIDA has the international quality certificate ISO9001:2008

keywords:N/A

N/A

Total Funding

105

Number of Employees

$14.7M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Isida News

2022-03-22 - At night in Kyiv, a bunker becomes a hospital's maternity ward

In the Isida clinic in western Kyiv, the narrow basement hallway where the patients stay each night offers no privacy and little comfort.

2022-03-22 - Russian attacks hit at least 9 Ukrainian medical facilities, visual ...

Expectant mothers are cared for in a makeshift underground maternity ward of the Isida clinic in Kyiv on March 2. In normal times, the room...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$34.5M106N/AN/A
#2
$30.2M1127%N/A
#3
$16.7M1157%N/A
#4
$30M120-27%N/A
#5
$18.2M130-16%N/A